Pressmeddelanden från Nightingale Health
Igår 10:00
Nightingale Health
Nightingale Healthin sairastumisriskien tunnistus osaksi lontoolaisen Barnes Private Practice -lääkäriaseman vuosittaisia terveystarkastuksiaI förrgår 16:25Nightingale Health
Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health PlcI förrgår 08:45Nightingale Health
Nightingale Health etenee Yhdysvalloissa: New Yorkin osavaltio hyväksyi yhtiön ensimmäiset LDT-testit04 nov 08:00Nightingale Health
Nightingale Health's disease risk detection becomes part of a longevity membership at S-Thetics Clinic in the United Kingdom02 nov 14:00Nightingale Health
Alamar Biosciences ja Nightingale Health johtavat 80 000 UK Biobankin näytteen tutkimusta hermoston rappeumasairauksista28 okt 20:15Nightingale Health
Inside information: Nightingale Health signs USD 1 million proteomics agreement with Alzheimer's Research UK, for neurodegenerative disease research28 okt 15:35Nightingale Health
Sisäpiiritieto: Nightingale Health on allekirjoittanut LifeArcin kanssa yhden miljoonan Yhdysvaltain dollarin proteomiikkapalvelusopimuksen hermoston rappeumasairauksien tutkimukseen22 okt 08:30Nightingale Health
Nightingale Healthin sairastumisriskien tunnistus osaksi The Private GP Groupin vuosittaisia terveystarkastuksia Isossa-Britanniassa05 okt 09:10Nightingale Health
Nightingale Healthin sairastumisriskien tunnistus osaksi työttömien terveystarkastuksia Pohjois-Karjalan hyvinvointialueella01 okt 16:15Nightingale Health
Kutsu Nightingale Health Oyj:n varsinaiseen yhtiökokoukseen01 okt 07:30Nightingale Health
Nightingale Healthin vuosikertomus tilikaudelta 2025–2026 on julkaistu30 sep 19:09Nightingale Health
Inside information: Nightingale Health signs USD 6.5 million proteomics agreement with the Michael J. Fox Foundation for neurodegenerative disease research29 sep 08:00Nightingale Health
Nightingale Healthin sairastumisriskien tunnistus saataville Latviassa Skriden sydänklinikan kautta28 sep 11:56Nightingale Health
Conversion of Nightingale Health Plc’s Series A shares to Series B shares23 sep 08:52Nightingale Health
Nightingale Health and Archipelago Health enter into agreement to bring the Nightingale Health Check to the Crown Dependencies, Bermuda and the Caribbean22 sep 06:20Nightingale Health
Nightingale Health's Remote Health Check becomes part of Coronaria's new weight management service in Finland16 sep 08:00Nightingale Health
Nightingale Health Plc Financial Statements Release 1 July 2025 – 30 June 202614 sep 15:56Nightingale Health
Nightingale Healthin sairastumisriskien tunnistus osaksi julkista perusterveydenhuoltoa Etelä-Savossa: ilmoittautuminen Eloisan Hyvinvointilahjaan avautunut tänään09 sep 09:30Nightingale Health
Nightingale Health and Genom partner to bring blood-based risk detection to clinics and laboratories across Croatia19 aug 08:00Nightingale Health
US healthcare commercial leader Hugh Watson joins Nightingale Health as Chief Commercial Officer, Americas19 aug 08:00Nightingale Health
Muutoksia Nightingale Health Oyj:n johtoryhmässä18 aug 08:57Nightingale Health
Nightingale Healthin Remote Health Check osaksi Supernormalin lääkkeellistä painonpudotuspalvelua Suomessa17 aug 10:30Nightingale Health
Nightingale Health ja Personalised Health Clinics solmivat kumppanuuden ennaltaehkäisevän terveyden edistämiseksi Isossa-Britanniassa01 jul 15:00Nightingale Health
Nightingale Health and Archipelago Health partner to bring preventive screening to small-island health systems in the Crown Dependencies, Bermuda and the Caribbean29 jun 17:15Nightingale Health
Nightingale Health’s Board of Directors resolved on new stock option program08 jun 18:25Nightingale Health
Sisäpiiritieto, tulosvaroitus: Nightingale Health jatkaa kasvuaan mutta ei saavuta tämän tilikauden 50 prosentin kasvutavoitettaan: noin 2 miljoonan euron liikevaihto siirtyy seuraavalle tilikaudelle28 maj 10:00Nightingale Health
Nightingale Health joins South Savo Wellbeing Services County's preventive healthcare research project in Finland27 maj 15:45Nightingale Health
Nightingale Health Plc’s financial reporting and Annual General Meeting in financial year 2026–202722 maj 08:30Nightingale Health
Nightingale Health ja Formula 100 Health ovat solmineet kumppanuuden sairastumisriskien tunnistamisen integroimiseksi longevity-ohjelmiin Sveitsissä ja Etelä-Afrikassa21 maj 16:25Nightingale Health
Nightingale Health Plc – Managers’ Transactions – Olli Karhi18 maj 12:02Nightingale Health
Nightingale Health Plc: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)05 mar 08:00Nightingale Health
Nightingale Health's half-year report: Delivering clinical value for healthcare and moving toward 50% revenue growth, supported by a strong sales pipeline09 feb 20:30Nightingale Health
Inside information: Nightingale Health achieves major milestone in the United States: New York laboratory now holds a clinical laboratory permit from New York State18 dec 2025 14:00Nightingale Health
Uusi hyvinvointialue mukaan – Pohjois-Karjala ottaa käyttöön sairastumisriskien tunnistamisen osana julkista terveydenhuoltoa17 dec 2025 08:30Nightingale Health
Merkittävä tutkimus: Nightingale Healthin verianalyysi auttaa estämään 44 % enemmän sydäninfarkteja ja aivohalvauksia verrattuna nykyiseen terveydenhuollon käytäntöön12 dec 2025 13:55Nightingale Health
Nightingale Health Oyj uudistaa johtoryhmänsä kokoonpanoa tukemaan terveydenhuollon liiketoiminnan kasvuvaihetta08 dec 2025 09:35Nightingale Health
Change in Nightingale Health Plc’s Management Team26 nov 2025 10:00Nightingale Health
Terveystalo and Nightingale Health deepen strategic partnership – preventive healthcare available to all Terveystalo customers in Finland20 nov 2025 09:00Nightingale Health
Nightingale Health enables access to world’s largest metabolomics dataset through UK Biobank collaboration06 nov 2025 16:10Nightingale Health
Nightingale Health Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset05 nov 2025 11:50Nightingale Health
Nightingale Health partners with Alamar Biosciences to expand its unique multiomics offering with ultra-sensitive proteomics for brain health02 okt 2025 14:30Nightingale Health
Kutsu Nightingale Health Oyj:n varsinaiseen yhtiökokoukseen02 okt 2025 08:00Nightingale Health
Nightingale Healthin vuosikertomus tilikaudelta 2024–2025 on julkaistu25 sep 2025 11:10Nightingale Health
Breakthrough in cardiovascular disease risk assessment – Nightingale Health to offer Lp(a) risk detection as part of its routine health check18 sep 2025 08:00Nightingale Health
Nightingale Health Plc Financial Statements Release 1 July 2024 – 30 June 202516 sep 2025 09:25Nightingale Health
Inside information: Nightingale Health selected as multiomics provider for EUR 2.4 million research project08 sep 2025 15:10Nightingale Health
Nightingale Health Oyj:n EMP-osakkeiden muunto B-sarjan osakkeiksi07 jul 2025 07:00Nightingale Health
Nightingale Health valittu palveluntarjoajaksi merkittävään italialaiseen väestötutkimukseen02 jul 2025 11:55Nightingale Health
Sisäpiiritieto, tulosvaroitus: Nightingale Healthin liikevaihto kasvaa, ja oikaistu käyttökate heikkenee edelliseen tilikauteen verrattuna30 jun 2025 16:15Nightingale Health
Nightingale Healthin laboratorio Yhdysvalloissa nyt avattu16 jun 2025 08:35Nightingale Health
Maailmanlaajuisesti ainutlaatuinen ennaltaehkäisevän terveydenhuollon hanke käynnistyy Suomessa: julkinen terveydenhuolto ottaa käyttöön Nightingale Healthin sairastumisriskejä tunnistavan teknologian13 jun 2025 10:50Nightingale Health
Nightingale Health vahvistaa kaupallista toimintaansa nimittämällä uuden johtajan EMEA-alueelle12 jun 2025 15:15Nightingale Health
Nightingale Healthin johtoryhmän jäsenet Minja Salmio ja Satu Saksman saivat tunnustusta erinomaisesta johtajuudesta09 jun 2025 15:15Nightingale Health
Nightingale Healthin hallitus on päättänyt uudesta optio-ohjelmasta02 maj 2025 15:45Nightingale Health
Muutoksia Nightingale Health Oyj:n johtoryhmässä23 apr 2025 17:15Nightingale Health
Conversion of Nightingale Health Plc’s Series A shares to Series B shares10 apr 2025 08:30Nightingale Health
Nightingale Health’s laboratory implementation in the United States progresses as planned – opens first to medical research customers in Summer 202521 mar 2025 12:00Nightingale Health
Trading in Nightingale Health’s B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US18 mar 2025 10:30Nightingale Health
Nightingale Health Plc’s listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 202517 mar 2025 15:15Nightingale Health
The Finnish Financial Supervisory Authority has approved Nightingale Health Plc’s Finnish prospectus17 mar 2025 12:55Nightingale Health
Nightingale Health establishes ADR program in the US – trading in Company’s B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US12 mar 2025 13:30Nightingale Health
Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki06 mar 2025 08:00Nightingale Health
Nightingale Health’s half-year report: International expansion continues in Southeast Asia and the United States28 feb 2025 11:35Nightingale Health
Nightingale Health to publish half-year report for July – December 2024 on 6 March 202527 feb 2025 13:15Nightingale Health
Nightingale Health announces the development of innovative LLM based tool to empower anyone to take informed decisions to lower disease risks07 feb 2025 13:15Nightingale Health
Nightingale Health announces its updated regulatory plan in the United States27 jan 2025 08:00Nightingale Health
Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region23 jan 2025 10:00Nightingale Health
Nightingale Health announces the performance metrics of its latest generation disease risk assessments to be rolled out in Singapore and the United States23 dec 2024 13:00Nightingale Health
Conversion of Nightingale Health Plc’s EMP shares to Series B shares20 dec 2024 16:35Nightingale Health
Nightingale Health Plc – Managers’ Transactions – Olli Karhi18 dec 2024 20:35Nightingale Health
Nightingale Health Plc appoints Lago Kapital as liquidity provider13 dec 2024 14:50Nightingale Health
Nightingale Health Plc: Subscription of Series B shares with option rights04 dec 2024 09:00Nightingale Health
Study published in Nature Communications: Nightingale Health outperforms genetic testing in chronic disease risk detection and makes the promise of preventative health a reality29 nov 2024 10:30Nightingale Health
Nightingale Health announces opening of its Singapore laboratory27 nov 2024 13:20Nightingale Health
Inside information: Nightingale Health is investigating the transfer of its B shares to the Main Market of Nasdaq Helsinki and adding the OTCQX market as an additional trading venue in the U.S.14 nov 2024 08:15Nightingale Health
Nightingale Health Asia achieves ISO 13485:2016 certification and completes regulatory readiness to launch its blood testing service in Singapore08 nov 2024 16:00Nightingale Health
Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc06 nov 2024 08:45Nightingale Health
Renowned international expert in medicine Dr. Charles Alessi joins Nightingale Health UK as Chief Medical Officer30 okt 2024 08:35Nightingale Health
Nightingale Health and Boston Heart Diagnostics have successfully completed their pilot and move to the production phase expanding the use of Nightingale’s Health Check in the US10 okt 2024 12:00Nightingale Health
Notice to the Annual General Meeting of Nightingale Health Plc10 okt 2024 08:00Nightingale Health
Nightingale Health’s Annual Report for financial year 2023–2024 has been published09 okt 2024 13:30Nightingale Health
Conversion of Nightingale Health Plc’s Series A shares to Series B shares20 sep 2024 12:45Nightingale Health
Nightingale Health’s Board of Directors resolved on amendment to CEO’s incentive program20 sep 2024 08:00Nightingale Health
Nightingale Health Plc Financial Statements Release 1 July 2023 – 30 June 202419 sep 2024 12:00Nightingale Health
Nightingale Health receives third regulatory approval for healthcare use from Health Sciences Authority in Singapore05 sep 2024 13:30Nightingale Health
Nightingale Health to publish Financial Statements Release for financial year July 2023 – June 2024 on 20 September 202420 aug 2024 08:45Nightingale Health
Nightingale Health attains UKCA marking for its blood analysis technology to bring its technology to healthcare use in the United Kingdom20 aug 2024 08:15Nightingale Health
Nightingale Health receives additional regulatory approval for healthcare use from Health Sciences Authority in Singapore06 aug 2024 17:00Nightingale Health
Nightingale Health and U.S.-based Phenome Health announce a partnership to strive towards the most transformational change in the history of healthcare04 jul 2024 13:35Nightingale Health
Nightingale Health Plc – Managers’ transactions – Olli Karhi03 jul 2024 15:35Nightingale Health
Summary of Financial Year 7/2023 - 6/2024: Nightingale Health achieved several breakthroughs in adopting the company’s technology in healthcare28 jun 2024 13:00Nightingale Health
Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel28 jun 2024 08:35Nightingale Health
Inside information: Nightingale Health and Boston Heart Diagnostics enter strategic partnership to sell Nightingale’s Health Check in the United States27 jun 2024 15:15Nightingale Health
Nightingale Health and ZOE expand research collaboration to include self-collected blood samples27 jun 2024 13:45Nightingale Health
Nightingale Health acquires all intellectual property assets of the Velvet™ blood collection device and secures its position as the sole provider of a fully integrated remote health check solution18 jun 2024 16:25Nightingale Health
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)18 jun 2024 16:15Nightingale Health
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Pasi Soininen)18 jun 2024 16:05Nightingale Health
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Teemu Suna)18 jun 2024 14:20Nightingale Health
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Antti Kangas)11 jun 2024 13:50Nightingale Health
Conversion of Nightingale Health Plc’s Series A shares to Series B shares